Valaciclovir Actavis 1000

Země: Nový Zéland

Jazyk: angličtina

Zdroj: Medsafe (Medicines Safety Authority)

Aktivní složka:

Valaciclovir hydrochloride monohydrate 1223.4mg equivalent to valaciclovir base 1000 mg

Dostupné s:

Teva Pharma (New Zealand) Limited

INN (Mezinárodní Name):

Valaciclovir hydrochloride monohydrate 1223.4 mg (equivalent to valaciclovir base 1000 mg)

Dávkování:

1000 mg

Léková forma:

Film coated tablet

Složení:

Active: Valaciclovir hydrochloride monohydrate 1223.4mg equivalent to valaciclovir base 1000 mg Excipient: Magnesium stearate Microcrystalline cellulose Opadry white Y-5-7068 Povidone

Jednotky v balení:

Blister pack, PVC/Al, 7 tablets

Třída:

Prescription

Druh předpisu:

Prescription

Výrobce:

Mylan Laboratories Limited

Terapeutické indikace:

Valaciclovir Actavis is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

Přehled produktů:

Package - Contents - Shelf Life: Blister pack, PVC/Al - 7 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 21 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 56 tablets - 24 months from date of manufacture stored at or below 25°C

Datum autorizace:

2013-02-01